Picture of MGC Pharmaceuticals logo

MXC MGC Pharmaceuticals Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for MGC Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-0.783-2.41-3.44-3.32-4.24
Other Operating Cash Flow
Cash from Operating Activities-5.89-6.35-9.96-12-12.2
Capital Expenditures-0.459-0.377-0.962-3.33-2.69
Purchase of Fixed Assets
Other Investing Cash Flow Items0.119-0.57-0.0081.831.58
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.341-0.947-0.97-1.49-1.11
Financing Cash Flow Items-0.317-0.009-0.788-1.2-0.703
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.70.02710.517.19.74
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.5-7.5-0.4813.56-3.55

Or unlock with your email

Or unlock with your email